Pulsed magnetic field treatment ameliorates the progression of peripheral neuropathy by modulating the neuronal oxidative stress, apoptosis and angiogenesis in a rat model of experimental diabetes

References

• Allen, D.A., Yaqoob, M.M., and Harwood, S.M., 2005. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. The journal of nutritional biochemistry, 16 (12), 705–713.
   PubMed Web of Science ®Google Scholar
• Calcutt, N.A., et al., 2009. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nature reviews. Drug discovery, 8 (5), 417–429.
   PubMed Web of Science ®Google Scholar
• Calcutt, N.A., Freshwater, J.D., and Mizisin, A.P., 2004. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia, 47 (4), 718–724.
   PubMed Web of Science ®Google Scholar
• Cameron, N.E., et al., 2005. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Annals of the New York Academy of Sciences, 1043, 784–792.
   PubMed Web of Science ®Google Scholar
• Chan, L., et al., 2011. Pathogenesis of diabetic neuropathy: bad to the bone. Annals of the New York Academy of Sciences, 1240, 70–76.
   PubMed Web of Science ®Google Scholar
• Christianson, J.A., et al., 2007. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience, 145 (1), 303–313.
   PubMed Web of Science ®Google Scholar
• Coppey, L.J., et al., 2001. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 50 (8), 1927–1937.
   PubMed Web of Science ®Google Scholar
• Costin, G.E., Birlea, S.A., and Norris, D.A., 2012. Trends in wound repair: cellular and molecular basis of regenerative therapy using electromagnetic fields. Current molecular medicine, 12 (1), 14–26.
   PubMed Web of Science ®Google Scholar
• Deli, G., et al., 2013. Diabetic neuropathies: diagnosis and management. Neuroendocrinology, 98 (4), 267–280.
   PubMed Web of Science ®Google Scholar
• Devarakonda, K. and Stanley, S., 2018. Investigating metabolic regulation using targeted neuromodulation. Annals of the New York Academy of Sciences, 1411 (1), 83–95.
   PubMed Web of Science ®Google Scholar
• Erel, O., 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical biochemistry, 37 (4), 277–285.
   PubMed Web of Science ®Google Scholar
• Erel, O., 2005. A new automated colorimetric method for measuring total oxidant status. Clinical biochemistry, 38 (12), 1103–1111.
   PubMed Web of Science ®Google Scholar
• Fox, A., et al., 1999. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain, 81 (3), 307–316.
   PubMed Web of Science ®Google Scholar
• Freeman, R., et al., 2014. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain, 155 (2), 367–376.
   PubMed Web of Science ®Google Scholar
• Friedman, J., 2011. Why is the nervous system vulnerable to oxidative stress? In: N. Gadoth and H.H. Göbel, eds. Oxidative stress and free radical damage in neurology. Totowa, NJ: Humana Press, 19–27.
   Google Scholar
• Güemes Gonzalez, A., Etienne-Cummings, R., and Georgiou, P., 2020. Closed-loop bioelectronic medicine for diabetes management. Bioelectronic medicine, 6, 11.
   PubMedGoogle Scholar
• Hug, K. and Roosli, M., 2012. Therapeutic effects of whole-body devices applying pulsed electromagnetic fields (PEMF): a systematic literature review. Bioelectromagnetics, 33 (2), 95–105.
   PubMed Web of Science ®Google Scholar
• Lei, T., et al., 2013. Therapeutic effects of 15 Hz pulsed electromagnetic field on diabetic peripheral neuropathy in streptozotocin-treated rats. PLos one, 8 (4), e61414.
   PubMed Web of Science ®Google Scholar
• Leinninger, G.M., Vincent, A.M., and Feldman, E.L., 2004. The role of growth factors in diabetic peripheral neuropathy. Journal of the peripheral nervous system : JPNS, 9 (1), 26–53.
   PubMed Web of Science ®Google Scholar
• Marangoni, M.N., et al., 2014. The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes. Cardiovascular diabetology, 13, 11.
   PubMed Web of Science ®Google Scholar
• Markov, M.S., 2007. Expanding use of pulsed electromagnetic field therapies. Electromagnetic biology and medicine, 26 (3), 257–274.
   PubMed Web of Science ®Google Scholar
• Mert, T., 2017. Pulsed magnetic field treatment as an anti-neuropathic pain. Reviews in the neurosciences, 28 (7), 751–758.
   PubMed Web of Science ®Google Scholar
• Mert, T., et al., 2013. Clodronate changes neurobiological effects of pulsed magnetic field on diabetic rats with peripheral neuropathy. Electromagnetic biology and medicine, 32 (3), 342–354.
   PubMed Web of Science ®Google Scholar
• Mert, T., et al., 2015. Modulation of cytokine levels in ameliorative effects of pulsed magnetic field on an experimental model of chronic constriction injury. International journal of radiation biology, 91 (7), 596–602.
   PubMed Web of Science ®Google Scholar
• Mert, T., et al., 2014. Pain-relieving effects of pulsed magnetic fields in a rat model of carrageenan-induced hindpaw inflammation. International journal of radiation biology, 90 (1), 95–103.
   PubMed Web of Science ®Google Scholar
• Obrosova, I.G., 2009. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics : the journal of the American Society for Experimental Neurotherapeutics, 6 (4), 638–647.
   PubMed Web of Science ®Google Scholar
• Risau, W., 1997. Mechanisms of angiogenesis. Nature, 386 (6626), 671–674.
   PubMed Web of Science ®Google Scholar
• Said, G., 2007. Diabetic neuropathy – a review. Nature clinical practice. Neurology, 3 (6), 331–340.
   PubMedGoogle Scholar
• Sandireddy, R., et al., 2014. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. International journal of endocrinology, 2014, 674987.
   PubMed Web of Science ®Google Scholar
• Schmeichel, A.M., Schmelzer, J.D., and Low, P.A., 2003. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes, 52 (1), 165–171.
   PubMed Web of Science ®Google Scholar
• Seicol, B.J., et al., 2019. Neuromodulation of metabolic functions: from pharmaceuticals to bioelectronics to biocircuits. Journal of biological engineering, 13, 67.
   PubMed Web of Science ®Google Scholar
• Shamji, M.F., De Vos, C., and Sharan, A., 2017. The advancing role of neuromodulation for the management of chronic treatment-refractory pain. Neurosurgery, 80 (3S), S108–S113.
   PubMedGoogle Scholar
• Themistocleous, A.C., et al., 2016. The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain, 157 (5), 1132–1145.
   PubMed Web of Science ®Google Scholar
• Totsch, S.K., et al., 2016. Total western diet alters mechanical and thermal sensitivity and prolongs hypersensitivity following complete Freund’s Adjuvant in Mice. The journal of pain: official journal of the American Pain Society, 17 (1), 119–125.
   PubMed Web of Science ®Google Scholar
• Vincent, A.M., et al., 2005. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB Journal: official Publication of the Federation of American Societies for Experimental Biology, 19 (6), 638–640.
   PubMedGoogle Scholar
• Yadlapalli, J.S.K., et al., 2018. Pinprick hypo- and hyperalgesia in diabetic rats: Can diet content affect experimental outcome? Neuroscience letters, 673, 24–27.
   PubMed Web of Science ®Google Scholar
• Yagihashi, S., Yamagishi, S., and Wada, R., 2007. Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes research and clinical practice, 77, 184–189.
   Web of Science ®Google Scholar
• Yang, J., et al., 2018. Pulsed electromagnetic fields alleviate streptozotocin-induced diabetic muscle atrophy. Molecular medicine reports, 18 (1), 1127–1133.
   PubMed Web of Science ®Google Scholar